Decentralized Clinical Trials: The Patient Perspective – Part 2

Decentralized Clinical Trials: The Patient Perspective – Part 2

Posted by Elizabeth Gargill on Thu, Sep 30, 2021


Getting Decentralized Right

What Matters to Patients

In Part 2 of our two-part interview with Phil Kelly, we delve further into the patient perspective on decentralized clinical trials. We ask Phil Kelly to share his thoughts on patient needs, tools, technologies, and the patient experience.

If you are conducting a decentralized clinical trial or planning for one, this is a must-see segment, with valuable insight to leverage for success.

Watch Now


About Phil Kelly

Phil was diagnosed with bladder cancer almost 11 years ago, and after he completed his active treatment, he drew on the experience to help others. He is actively involved with one of the two bladder cancer charities in the UK, Action Bladder Cancer UK, initially as a trustee and more recently as a patient adviser. He has also been involved in providing one-on-one support for individual bladder cancer patients in different situations and at different stages of their treatment. 

Missed Part 1? Click Here to Watch.

Pharma15 Live Logo

Topics: Patient, Pharma15 Live!, Most Viewed, Patient Voice, Patient Centric, Decentralized Clinical Trials, Phil Kelly